Skip to main content
Erschienen in: Journal of Bone and Mineral Metabolism 5/2022

29.08.2022 | Original Article

Trends in osteoporosis prevalence over a 10-year period in Japan: the ROAD study 2005–2015

verfasst von: Noriko Yoshimura, Toshiko Iidaka, Chiaki Horii, Shigeyuki Muraki, Hiroyuki Oka, Hiroshi Kawaguchi, Kozo Nakamura, Toru Akune, Sakae Tanaka

Erschienen in: Journal of Bone and Mineral Metabolism | Ausgabe 5/2022

Einloggen, um Zugang zu erhalten

Abstract

Introduction

This study aimed to clarify the trends in the prevalence of osteoporosis among general inhabitants using population-based cohort data of the baseline and the survey 10 years later.

Materials and Methods

The baseline survey of the Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study was conducted in 2005–2007; 1690 participants (596 men, 1094 women, mean age 65.2 years) completed all examinations of osteoporosis, including a questionnaire of medical information in the present/past and bone mineral density measurement using dual-energy absorptiometry. The fourth survey was performed in 2015–2016; 1906 individuals (637 men, 1269 women, 65.0 years) completed assessments identical to those at the baseline survey. Osteoporosis was defined using the World Health Organization criteria.

Results

The prevalence of lumbar spine (L2–L4) osteoporosis at the baseline survey was 13.6% (men, 3.4%; women, 19.2%) and that at the fourth survey was 9.7% (men, 1.4%; women, 13.9%), which decreased significantly (p < 0.01), while that of the femoral neck was not significantly different between the baseline and fourth surveys. Regarding the prevalence of osteoporosis of L2–L4 or the femoral neck, the prevalence of osteoporosis in women aged ≥ 70 was 38.8% at the fourth survey and 48.9% at the baseline study; thus, the prevalence at the fourth survey was significantly lower than that at the baseline survey (p < 0.01).

Conclusions

In the population-based survey with a 10-year interval, the prevalence of osteoporosis at lumbar spine tended to decrease significantly. This preferable change in osteoporosis could contribute to the decrease in the occurrence of osteoporotic fracture in the future.
Literatur
3.
Zurück zum Zitat Yoshimura N, Muraki S, Oka H, Mabuchi A, En-Yo Y, Yoshida M, Saika A, Yoshida H, Suzuki T, Yamamoto S, Ishibashi H, Kawaguchi H, Nakamura K, Akune T (2009) Prevalence of knee osteoarthritis, lumbar spondylosis and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability study. J Bone Miner Metab 27:620–628. https://doi.org/10.1007/s00774-009-0080-8CrossRefPubMed Yoshimura N, Muraki S, Oka H, Mabuchi A, En-Yo Y, Yoshida M, Saika A, Yoshida H, Suzuki T, Yamamoto S, Ishibashi H, Kawaguchi H, Nakamura K, Akune T (2009) Prevalence of knee osteoarthritis, lumbar spondylosis and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability study. J Bone Miner Metab 27:620–628. https://​doi.​org/​10.​1007/​s00774-009-0080-8CrossRefPubMed
5.
Zurück zum Zitat Committee for 2011 Guidelines for Prevention and Treatment of Osteoporosis (Director, Orimo H) (2011) The guidelines for prevention and treatment of osteoporosis. Life Science Publishing Co. Ltd, Tokyo Committee for 2011 Guidelines for Prevention and Treatment of Osteoporosis (Director, Orimo H) (2011) The guidelines for prevention and treatment of osteoporosis. Life Science Publishing Co. Ltd, Tokyo
6.
Zurück zum Zitat Orimo H, Hayashi Y, Fukunaga M, Sone T, Fujiwara S, Shiraki M, Kushida K, Miyamoto S, Soen S, Nishimura J, Oh-Hashi Y, Hosoi T, Gorai I, Tanaka H, Igai T, Kishimoto H, Osteoporosis Diagnostic Criteria Review Committee: Japanese Society for Bone and Mineral Research (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19:331–337. https://doi.org/10.1007/s007740170001CrossRefPubMed Orimo H, Hayashi Y, Fukunaga M, Sone T, Fujiwara S, Shiraki M, Kushida K, Miyamoto S, Soen S, Nishimura J, Oh-Hashi Y, Hosoi T, Gorai I, Tanaka H, Igai T, Kishimoto H, Osteoporosis Diagnostic Criteria Review Committee: Japanese Society for Bone and Mineral Research (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19:331–337. https://​doi.​org/​10.​1007/​s007740170001CrossRefPubMed
7.
Zurück zum Zitat Committee for 2015 Guidelines for Prevention and Treatment of Osteoporosis (Director, Orimo H) (2015) The guidelines for prevention and treatment of osteoporosis. Life Science Publishing Co. Ltd, Tokyo Committee for 2015 Guidelines for Prevention and Treatment of Osteoporosis (Director, Orimo H) (2015) The guidelines for prevention and treatment of osteoporosis. Life Science Publishing Co. Ltd, Tokyo
8.
Zurück zum Zitat World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1–129 World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1–129
9.
Zurück zum Zitat Kanis JA, Adachi JD, Cooper C, Clark P, Cummings SR, Diaz-Curiel M, Harvey N, Hiligsmann M, Papaioannou A, Pierroz DD, Silverman SL, Szulc P, Epidemiology and Quality of Life Working Group of IOF (2013) Standardising the descriptive epidemiology of osteoporosis: recommendations from the Epidemiology and Quality of Life Working Group of IOF. Osteoporos Int 24:2763–2764CrossRef Kanis JA, Adachi JD, Cooper C, Clark P, Cummings SR, Diaz-Curiel M, Harvey N, Hiligsmann M, Papaioannou A, Pierroz DD, Silverman SL, Szulc P, Epidemiology and Quality of Life Working Group of IOF (2013) Standardising the descriptive epidemiology of osteoporosis: recommendations from the Epidemiology and Quality of Life Working Group of IOF. Osteoporos Int 24:2763–2764CrossRef
10.
Zurück zum Zitat Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T (2010) Cohort profile: research on osteoarthritis/osteoporosis against disability study. Int J Epidemiol 39:988–995CrossRef Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T (2010) Cohort profile: research on osteoarthritis/osteoporosis against disability study. Int J Epidemiol 39:988–995CrossRef
11.
Zurück zum Zitat Yoshimura N, Kakimoto T, Nishioka M, Kishi T, Iwasaki H, Niwa T, Morioka S, Sakata T, Hashimoto T (1997) Evaluation of reproducibility of bone mineral density measured by dual energy X-ray absorptiometry (Lunar DPX-L). J Wakayama Med Soc 48:461–466 Yoshimura N, Kakimoto T, Nishioka M, Kishi T, Iwasaki H, Niwa T, Morioka S, Sakata T, Hashimoto T (1997) Evaluation of reproducibility of bone mineral density measured by dual energy X-ray absorptiometry (Lunar DPX-L). J Wakayama Med Soc 48:461–466
14.
Zurück zum Zitat Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8:136. https://doi.org/10.1007/s11657-013-0136-1CrossRefPubMedPubMedCentral Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8:136. https://​doi.​org/​10.​1007/​s11657-013-0136-1CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Wright NC, Looker AC, Saag KG, Curtis JR, Delzell ES, Randall S, Dawson-Huges B (2014) The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. Bone Miner Res 29:2520–2526. https://doi.org/10.1002/jbmr.2269CrossRef Wright NC, Looker AC, Saag KG, Curtis JR, Delzell ES, Randall S, Dawson-Huges B (2014) The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. Bone Miner Res 29:2520–2526. https://​doi.​org/​10.​1002/​jbmr.​2269CrossRef
17.
Zurück zum Zitat Looker A, Borrud LG, Dawson-Hughes B, Shepherd JA, Wright NC (2012) Osteoporosis or low bone mass at the femur neck or lumbar spine in older adults: United States, 2005–2008. NCHS Data Brief 1–8 Looker A, Borrud LG, Dawson-Hughes B, Shepherd JA, Wright NC (2012) Osteoporosis or low bone mass at the femur neck or lumbar spine in older adults: United States, 2005–2008. NCHS Data Brief 1–8
Metadaten
Titel
Trends in osteoporosis prevalence over a 10-year period in Japan: the ROAD study 2005–2015
verfasst von
Noriko Yoshimura
Toshiko Iidaka
Chiaki Horii
Shigeyuki Muraki
Hiroyuki Oka
Hiroshi Kawaguchi
Kozo Nakamura
Toru Akune
Sakae Tanaka
Publikationsdatum
29.08.2022
Verlag
Springer Nature Singapore
Erschienen in
Journal of Bone and Mineral Metabolism / Ausgabe 5/2022
Print ISSN: 0914-8779
Elektronische ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-022-01352-4

Weitere Artikel der Ausgabe 5/2022

Journal of Bone and Mineral Metabolism 5/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.